JP2018531914A5 - - Google Patents

Info

Publication number

JP2018531914A5

JP2018531914A5 JP2018513505A JP2018513505A JP2018531914A5 JP 2018531914 A5 JP2018531914 A5 JP 2018531914A5 JP 2018513505 A JP2018513505 A JP 2018513505A JP 2018513505 A JP2018513505 A JP 2018513505A JP 2018531914 A5 JP2018531914 A5 JP 2018531914A5

Authority

JP

Japan

Prior art keywords

composition

tgf

antagonist

combination

cancer

Prior art date

2016-09-14

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Links

• Espacenet
• Global Dossier
• Discuss

• 239000005557 antagonist Substances 0.000 claims description 164
• 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 100
• 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 100
• 206010028980 Neoplasm Diseases 0.000 claims description 81
• 201000011510 cancer Diseases 0.000 claims description 81
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims description 72
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims description 72
• 239000012634 fragment Substances 0.000 claims description 37
• 108091005735 TGF-beta receptors Proteins 0.000 claims description 32
• 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 claims description 32
• 230000028993 immune response Effects 0.000 claims description 32
• 230000005867 T cell response Effects 0.000 claims description 30
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 30
• 210000004027 cell Anatomy 0.000 claims description 20
• 239000000427 antigen Substances 0.000 claims description 18
• 102000036639 antigens Human genes 0.000 claims description 18
• 108091007433 antigens Proteins 0.000 claims description 18
• 150000001413 amino acids Chemical group 0.000 claims description 15
• 108020001507 fusion proteins Proteins 0.000 claims description 14
• 102000037865 fusion proteins Human genes 0.000 claims description 14
• 230000002708 enhancing effect Effects 0.000 claims description 11
• 238000004519 manufacturing process Methods 0.000 claims description 10
• 230000037455 tumor specific immune response Effects 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
• 102000009027 Albumins Human genes 0.000 claims description 5
• 108010088751 Albumins Proteins 0.000 claims description 5
• 108010002350 Interleukin-2 Proteins 0.000 claims description 5
• 239000002202 Polyethylene glycol Substances 0.000 claims description 5
• 102000039446 nucleic acids Human genes 0.000 claims description 5
• 108020004707 nucleic acids Proteins 0.000 claims description 5
• 150000007523 nucleic acids Chemical class 0.000 claims description 5
• 229920001223 polyethylene glycol Polymers 0.000 claims description 5
• 229920001184 polypeptide Polymers 0.000 claims description 5
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
• 210000002966 serum Anatomy 0.000 claims description 5
• 150000003384 small molecules Chemical class 0.000 claims description 5
• 230000035755 proliferation Effects 0.000 claims description 4
• 102000005962 receptors Human genes 0.000 claims 7
• 108020003175 receptors Proteins 0.000 claims 7
• 238000000034 method Methods 0.000 description 60